Загрузка...
A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy
BACKGROUND: This randomized, double-blind, placebo-controlled study evaluated dose-response relationships of lisdexamfetamine dimesylate when used as augmentation for major depressive disorder in individuals exhibiting inadequate responses to antidepressant monotherapy. METHODS: Eligible adults (18–...
Сохранить в:
| Опубликовано в: : | J Psychopharmacol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606302/ https://ncbi.nlm.nih.gov/pubmed/28857719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0269881117722998 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|